Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
970 DKK | -0.34% | +0.41% | +38.95% |
16/07 | Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron | DJ |
16/07 | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.95% | 63TCr | |
+61.53% | 86TCr | |
-3.66% | 36TCr | |
+15.06% | 32TCr | |
+9.18% | 30TCr | |
+5.89% | 23TCr | |
+16.53% | 23TCr | |
+15.67% | 18TCr | |
+2.47% | 16TCr | |
+2.41% | 13TCr |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- NOVO NORDISK : JP Morgan maintains a Buy rating